L'Institut Tropical et de Santé Publique Suisse

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.

Project 2

RTS,S: most advanced candidate for a malaria vaccine. Swiss TPH helped coordinate a large-scale clinical trail involving more than 16,000 children. Swiss TPH also calculated the long-term impact and cost-effectiveness of RTS,S in 43 African countries.

Pays

burkina-faso gabon ghana kenya malawi mozambique tanzania

Impact

16,000 children

Durée

2009 - 2014

Activité

Innovation & Research

Medicines for Malaria Venture

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.

Project 5

Chemoprevention of seasonal P. falciparum malaria in children.

Pays

burkina-faso cameroon chad gambia guinea guinea-bissau ghana mali niger nigeria senegal togo

Impact

29 million children

Activité

Treatment

Syngenta

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.


Project 1

Launch of ACTELLIC 300CS for IRS & following establishment of NgenIRS project. The project's aim is to make the most effective, long lasting insecticides available to malaria control programmes to support insecticide resistance management strategies.

Pays

benin burkina-faso ethiopia ghana kenya madagascar mali malawi mozambique rwanda tanzania uganda zambia zimbabwe

Impact

6.7 million units of ACTELLIC procured

Durée

2013/2016 - ongoing

Activité

Vector control